Christopher Peetz
President and CEO at Mirum Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Mirum Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Mirum Pharmaceuticals Inc. May 29, 202599.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +20,000 | $2.94 | $58,720 |
| Nov 4, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −20,000 | $90.00 | $1,800,000 |
| Oct 6, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +5,305 | $19.19 | $101,803 |
| Oct 6, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +6,892 | $15.87 | $109,376 |
| Sep 1, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +30,000 | $2.94 | $88,200 |
| Sep 1, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −8,312 | $98.08 | $815,241 |
| Sep 1, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −21,688 | $98.91 | $2,145,160 |
| Aug 10, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +20,000 | $2.94 | $58,800 |
| Aug 10, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −11,683 | $98.51 | $1,150,892 |
| Aug 10, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −6,017 | $99.25 | $597,187 |
| Aug 10, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −2,300 | $100.14 | $230,322 |
| Jul 15, 2026 | Arcutis Biotherapeutics Inc. | Grant or award | +4,315 | — | — |
| Jul 6, 2026 | Mirum Pharmaceuticals Inc. | Option exercise | +20,000 | $2.94 | $58,800 |
| Jul 6, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −12,134 | $121.65 | $1,476,101 |
| Jul 6, 2026 | Mirum Pharmaceuticals Inc. | Open-market sale | −4,181 | $122.34 | $511,504 |
Questions about Christopher Peetz
What boards is Christopher Peetz on?
Christopher Peetz sits on the boards of Arcutis Biotherapeutics Inc. and Mirum Pharmaceuticals Inc.
What company is Christopher Peetz the CEO of?
Christopher Peetz is President and CEO of Mirum Pharmaceuticals Inc.
How long has Christopher Peetz served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.